The anti-apoptosis protein, survivin, mediates gastric epithelial cell cytoprotection against ethanol-induced injury via activation of the p34 cdc2 cyclin-dependent kinase

Journal of Cellular Physiology

Volumn 215, Issue 3, 2008, Pages 750-764

  Jones, Michael K ^a,b   Padilla, Oscar R ^a   Webb, Nicole A ^a   Norng, Manith ^a  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; CYCLIN DEPENDENT KINASE 1; SMALL INTERFERING RNA; SURVIVIN; MESSENGER RNA; MICROTUBULE ASSOCIATED PROTEIN; PHOSPHOPROTEIN; SURVIVIN PROTEIN, RAT; THREONINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; STOMACH EPITHELIUM; STOMACH INJURY; ANIMAL; APOPTOSIS; CYTOLOGY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; EPITHELIUM CELL; GENETICS; METABOLISM; PATHOLOGY; PHYSIOLOGY; PROTEIN SYNTHESIS; SPRAGUE DAWLEY RAT; STOMACH; STOMACH MUCOSA;

RATTUS;

ANIMALS; APOPTOSIS; CDC2 PROTEIN KINASE; CYTOPROTECTION; ENZYME ACTIVATION; EPITHELIAL CELLS; ETHANOL; GASTRIC MUCOSA; MALE; MICROTUBULE-ASSOCIATED PROTEINS; PHOSPHOPROTEINS; PROTEIN BIOSYNTHESIS; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER; STOMACH; THREONINE;

EID: 42949112099     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21358     Document Type: Article

References (52)

1. Atherton-Fessler S, Parker LL, Geahlen RL, Piwnica-Worms H. 1993. Mechanisms of p34cdc2 regulation. Mol Cell Biol 13:1675-1685.
2. Balaa MA. 1989. Release of protective products, different from prostaglandins, by rat stomachs exposed to mild irritant. Dig Dis Sci 34:429-435.
3. Brzozowski T, Konturek PC, Konturek SJ, Brzozowska I, Pawlik T. 2005. Role of prostaglandins in gastroprotection and gastric adaptation. J Physiol Pharmacol 56:33-55.
4. Chang CC, Heller JD, Kuo J, Huang RC. 2004. Tetra-O-methyl nordihydroguaiaretic acid induces growth arrest and cellular apoptosis by inhibiting Cdc2 and survivin expression. Proc Natl Acad Sci USA 101:13239-13244.
5. Chiou SK, Jones MK, Tarnawski AS. 2003a. Survivin - An anti-apoptosis protein: Its biological roles and implications for cancer and beyond. Med Sci Monit 9:P125-P129.
6. Chiou SK, Moon WS, Jones MK, Tarnawski AS. 2003b. Survivin expression in the stomach: Implications for mucosal integrity and protection. Biochem Biophys Res Commun 305:374-379.
7. Chiou SK, Tanigawa T, Akahoshi T, Abdelkari B, Jones MK, Tarnawski AS. 2005. Survivin: A novel target for indomethacin-induced gastric injury. Gastroenterology 128:63-73.
8. Clemens DL, Calisto LE, Sorrell MF, Tuma DL. 2003. Ethanol metabolism results in a G2/M cell-cycle arrest in recombinant Hep G2 cells. Hepatology 38:385-393.
9. Conte MS, Altieri DC. 2006. Survivin regulation of vascular injury. Trends Cardiovasc Med 16:114-117.
10. Culvenor JG, Weidemann MJ. 1976. Phytohaemagglutinin stimulation of rat thymus lymphocytes glycolysis. Biochim Biophys Acta 437:354-363.
11. De Azevedo WF, Leclerc S, Meijer L, Havlicek L, Strnad M, Kim SH. 1997. Inhibition of cyclin-dependent kinases by purine analogues: Crystal structure of human cdk2 complexed with roscovitine. Eur J Biochem 243:518-526.
12. Deguchi M, Shiraki K, Inoue H, Okano H, Ito T, Yamanaka T, Sugimoto K, Sakai T, Ohmori S, Murata K, Furusaka A, Hisatomi H, Nakano T. 2002. Expression of survivin during liver regeneration. Biochem Biophys Res Commun 297:59-64.
13. Fukuda S, Pelus LM. 2001. Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: Implication of survivin expression in normal hematopoiesis. Blood 98:2091-2100.
14. Gianani R, Jarboe E, Orlicky D, Frost M, Bobak J, Lehner R, Shroyer KR. 2001. Expression of survivin in normal, hyperplastic, and neoplastic colonic mucosa. Hum Pathol 32:119-125.
15. Gray NS, Wodicka L, Thunnissen AM, Norman TC, Kwon S, Espinoza FH, Morgan DO, Barnes G, Leclerc S, Meijer L, Kim SH, Lockhart DJ, Schultz PG. 1998. Exploiting chemical libraries, structure, and genomics in the search for kinase inhibitors. Science 281:533-538.
16. Guo W, Baluda MA, Park NH. 1997. Ethanol upregulates the expression of p21 WAF1/CIP1 and prolongs G1 transition via a p53-independent pathway in human epithelial cells. Oncogene 15:1143-1149.
17. Gyires K. 2005. Gastric mucosal protection: From prostaglandins to gene-therapy. Curr Med Chem 12:203-215.
18. Hawkey CJ, Kemp RT, Walt RP, Bhaskar NK, Davies J, Filipowicz B. 1988. Evidence that adaptive cytoprotection in rats is not mediated by prostaglandins. Gastroenterology 94:948-954.
19. Ko JK, Cho CH. 1996. Adaptive gastric mucosal cytoprotection in rats: Different models of action by three mild irritants. Digestion 57:54-59.
20. Ko JK, Cho CH. 1998. Histological study of mechanisms of adaptive cytoprotection on ethanol-induced mucosal damage in rat stomachs. Dig Dis Sci 43:1248-1257.
21. Kobayashi Y, Yukiue H, Sasaki H, Fukai I, Yokoyama T, Kiriyama M, Yamakawa Y, Maeda M, Fujii Y. 2002. Developmentally regulated expression of survivin in the human thymus. Hum Immunol 63:101-107.
22. Kokoska ER, Smith GS, Deshpande Y, Rieckenberg CL, Miller TA. 1998a. Adaptive cytoprotection induced by ethanol in human intestinal cells: Role of prostaglandins and calcium homeostasis. Ann Surg 228:123-130.
23. Kokoska ER, Smith GS, Rieckenberg CL, Deshpande Y, Banan A, Miller TA. 1998b. Adaptive cytoprotection against deoxycholate-induced injury in human gastric cells in vitro: Is there a role for endogenous prostaglandins? Dig Dis Sci 43:806-815.
24. Kokoska ER, Smith GS, Wolff AB, Deshpande Y, Rieckenberg CL, Banan A, Miller TA. 1998c. Role of calcium in adaptive cytoprotection and cell injury induced by deoxycholate in human gastric cells. Am J Physiol 275:G322-G330.
25. Krystof V, Lenobel R, Havlicek L, Kuzma M, Strnad M. 2002. Synthesis and biological activity of olomoucine II. Bioorg Med Chem Lett 12:3283-3286.
26. Lens SM, Vader G, Medema RH. 2006. The case for Survivin as mitotic regulator. Curr Opin Cell Biol 18:616-622.
27. Li F. 2005. Role of survivin and its splice variants in tumorigenesis. Br J Cancer 92:212-216.
28. Ma C, Lin H, Leonard SS, Shi X, Ye J, Luo J. 2003. Overexpression of ErbB2 enhances ethanol-stimulated intracellular signaling and invasion of human mammary epithelial and breast cancer cells in vitro. Oncogene 22:5281-5290.
29. Marusawa H, Matsuzawa S, Welsh K, Zou H, Armstrong R, Tamm I, Reed JC. 2003. HBXIP functions as a cofactor of survivin in apoptosis suppression. EMBO J 22:2729-2740.
30. Mutoh H, Ota S, Hiraishi H, Ivey KJ, Terano A, Sugimoto T. 1995. Adaptive cytoprotection in cultured rat gastric mucus-producing cells. Role of mucus and prostaglandin synthesis. Dig Dis Sci 40:872-878.
31. Norbury C, Blow J, Nurse P. 1991. Regulatory phosphorylation of the p34cdc2 protein kinase invertebrates. EMBO J 10:3321-3329.
32. O'Connor DS, Grossman D, Plescia J, Li F, Zhang H, Villa A, Tognin S, Marchisio PC, Altieri DC. 2000a. Regulation of apoptosis at cell division by p34cdc2 phosphorylation of survivin. Proc Natl Acad Sci USA 97:13103-13107.
33. O'Connor DS, Schechner JS, Adida C, Mesri M, Rothermel AL, Li F, Nath AK, Pober JS, Altieri DC. 2000b. Control of apoptosis during angiogenesis by survivin expression in endothelial cells. Am J Pathol 156:393-398.
34. O'Connor DS, Wall NR, Porter AC, Altieri DC. 2002. A p34(cdc2) survival checkpoint in cancer. Cancer Cell 2:43-54.
35. Patel R, Holt M, Philipova R, Moss S, Schulman H, Hidaka H, Whitaker M. 1999. Calcium/calmodulin-dependent phosphorylation and activation of human Cdc25-C at the G2/M phase transition in HeLa cells. J Biol Chem 274:7958-7968.
36. Peskar BM. 2001. Role of cydooxygenase isoforms in gastric mucosal defence. J Physiol Paris 95:3-9.
37. Pippin JW, Qu Q, Meijer L, Shankland SJ. 1997. Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist. J Clin Invest 100:2512-2520.
38. Robert A, Nezamis JE, Lancaster C, Davis JP, Field SO, Hanchar AJ. 1983. Mild irritants prevent gastric necrosis through "adaptive cytoprotection" mediated by prostaglandins. Am J Physiol 245:G113-G121.
39. Roberts EC, Shapiro PS, Nahreini TS, Pages G, Pouyssegur J, Ahn NG. 2002. Distinct cell cycle timing requirements for extracellular signal-regulated kinase and phosphoinositide 3-kinase signaling pathways in somatic cell mitosis. Mol Cell Biol 22:226-7241.
40. Rokutan K, Hirakawa T, Teshima S, Nakano Y, Miyoshi M, Kawai T, Konda E, Morinaga H, Nikawa T, Kishi K. 1998. Implications of heat shock/stress proteins for medicine and disease.J Med Invest 44:137-147.
41. Schmidt KL, Smith GS, Miller TA. 1989. Microscopic correlates of adaptive cytoprotection in an ethanol injury model. Histol Histopathol 4:105-115.
42. Simosa HF, Wang G, Sui X, Peterson T, Narra V, Altieri DC, Conte MS. 2005. Survivin expression is up-regulated in vascular injury and identifies a distinct cellular phenotype. J Vasc Surg 41:682-690.
43. Smith GS, Myers SI, Bartula LL, Miller TA. 1991. Adaptive cytoprotection against alcohol injury in the rat stomach is not due to increased prostanoid synthesis. Prostaglandins 41:207-223.
44. Suprynowicz FA, Groigno L, Whitaker M, Miller FJ, Sluder G, Sturrock J, Whalley T. 2000. Activation of protein kinase C alters p34(cdc2) phosphorylation state and kinase activity in early sea urchin embryos by abolishing intracellular Ca2+ transients. Biochem J 349:489-499.
45. Takeuchi K, Ogawa Y, Kagawa S, Ukawa H. 2002. Gastric ulcerogenic responses following barrier disruption in knockout mice lacking prostaglandin EP1 receptors. Aliment Pharmacol Ther 16:74-82.
46. Tanaka K, Nishimoto K, Tomisato W, Tsutsumi S, Hoshino T, Tsuchiya T, Mizushima T. 2004. Adaptive cytoprotection induced by pretreatment with ethanol protects against gastric cell damage by NSAIDs. Dig Dis Sci 49:210-217.
47. Tarnawski AS, Hollander D, Gergely H, Stachura J. 1985. Comparison of antacid, sucralfate, Cimetidine, and ranitidine in protection of the gastric mucosa against ethanol injury. Am J Med 79:19-23.
48. Tsutsumi S, Mima S, Tomisato W, Hoshino T, Tsuchiya T, Mizushima T. 2003. Molecular mechanism of adaptive cytoprotection induced by ethanol in human gastric cells. Exp Biol Med (Maywood) 228:1089-1095.
49. Wallace JL, Tigley AW. 1995. Review article: New insights into prostaglandins and mucosal defence. Aliment Pharmacol Ther 9:227-235.
50. Wheatley SP, McNeish IA. 2005. Survivin: A protein with dual roles in mitosis and apoptosis. Int Rev Cytol 247:35-88.
51. Wheatley SP, Barrett RM, Andrews PD, Medema RH, Morley SJ, SwedlowJR, Lens SMA. 2007. Phosphorylation by aurora-B negatively regulates survivin function during mitosis. Cell Cycle 6:1220-1230.
52. Xu Y, Fang F, Ludewig G, Jones G, Jones D. 2004. A mutation found in the promoter region of the human survivin gene is correlated to overexpression of survivin in cancer cells. DNA Cell Biol 23:527-537.